134 related articles for article (PubMed ID: 2415068)
1. [Kinetics of etoposide cytotoxicity against mouse P388 leukemia].
Takahashi K; Iwabuchi M
Gan To Kagaku Ryoho; 1985 Nov; 12(11):2190-5. PubMed ID: 2415068
[TBL] [Abstract][Full Text] [Related]
2. A murine model to evaluate the ability of in vitro clonogenic assays to predict the response to tumors in vivo.
Mirabelli CK; Sung CM; McCabe FL; Faucette LF; Crooke ST; Johnson RK
Cancer Res; 1988 Oct; 48(19):5447-54. PubMed ID: 3046738
[TBL] [Abstract][Full Text] [Related]
3. Differential effect of the calmodulin inhibitor trifluoperazine on cellular accumulation, retention, and cytotoxicity of anthracyclines in doxorubicin (adriamycin)-resistant P388 mouse leukemia cells.
Ganapathi R; Grabowski D; Rouse W; Riegler F
Cancer Res; 1984 Nov; 44(11):5056-61. PubMed ID: 6488165
[TBL] [Abstract][Full Text] [Related]
4. Chemotherapy with [SP-4-3-(R)]-[1,1-cyclobutanedicarboxylato(2-)](2- methyl-1,4-butanediamine-N,N')platinum (CI-973, NK121) in combination with standard agents against murine tumors in vivo.
Elliott WL; Roberts BJ; Howard CT; Leopold WR
Cancer Res; 1994 Aug; 54(16):4412-8. PubMed ID: 8044790
[TBL] [Abstract][Full Text] [Related]
5. Effects of quinidine and related compounds on cytotoxicity and cellular accumulation of vincristine and adriamycin in drug-resistant tumor cells.
Tsuruo T; Iida H; Kitatani Y; Yokota K; Tsukagoshi S; Sakurai Y
Cancer Res; 1984 Oct; 44(10):4303-7. PubMed ID: 6467192
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the synergistic potentiation of etoposide, doxorubicin, and vinblastine cytotoxicity by dipyridamole.
Howell SB; Hom D; Sanga R; Vick JS; Abramson IS
Cancer Res; 1989 Jun; 49(12):3178-83. PubMed ID: 2720673
[TBL] [Abstract][Full Text] [Related]
7. Cross-resistance of cultured murine leukemia vincristine-resistant P388 cells to vinblastine, vindesine, and bis (N-ethylidene vindesine) disulfide, disulfate.
Wilkoff LJ; Dulmadge EA
J Natl Cancer Inst; 1982 Jun; 68(6):1023-6. PubMed ID: 6953266
[TBL] [Abstract][Full Text] [Related]
8. Sensitivity of proliferating cultured murine pancreatic tumor cells to selected antitumor agents.
Wilkoff LJ; Dulmadge EA
J Natl Cancer Inst; 1986 Nov; 77(5):1163-9. PubMed ID: 3464801
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the in vivo antitumor activity and in vitro cytotoxic properties of auranofin, a coordinated gold compound, in murine tumor models.
Mirabelli CK; Johnson RK; Sung CM; Faucette L; Muirhead K; Crooke ST
Cancer Res; 1985 Jan; 45(1):32-9. PubMed ID: 3917372
[TBL] [Abstract][Full Text] [Related]
10. Cytotoxic synergy between flavopiridol (NSC 649890, L86-8275) and various antineoplastic agents: the importance of sequence of administration.
Bible KC; Kaufmann SH
Cancer Res; 1997 Aug; 57(16):3375-80. PubMed ID: 9269999
[TBL] [Abstract][Full Text] [Related]
11. In vitro pharmacodynamic assay for cancer drug development: application to crisnatol, a new DNA intercalator.
Adams DJ
Cancer Res; 1989 Dec; 49(23):6615-20. PubMed ID: 2819712
[TBL] [Abstract][Full Text] [Related]
12. [Antitumor effect of etoposide and its analogs].
Kuramochi H; Okamoto K; Nishikawa K; Nagamine S; Takahashi K
Gan To Kagaku Ryoho; 1985 Nov; 12(11):2196-201. PubMed ID: 4062319
[TBL] [Abstract][Full Text] [Related]
13. In vitro chemoseparation of leukemic cells from murine bone marrow using VP16-213: importance of stem cell assays.
Stiff PJ; Koester AR
Exp Hematol; 1987 Mar; 15(3):263-8. PubMed ID: 3545881
[TBL] [Abstract][Full Text] [Related]
14. Modulation of the in vitro cytotoxicity of seven anticancer drugs by protein synthesis inhibition using sparsomycin.
Zylicz Z; Hofs HP; Wagener DJ; Van Rennes H; Wessels JM; van den Broek LA; Ottenheijm HC
Anticancer Res; 1989; 9(6):1835-40. PubMed ID: 2483308
[TBL] [Abstract][Full Text] [Related]
15. Kinetics of cytotoxicity of VM-26 and VP-16-213 on L1210 leukemia and hematopoietic stem cells.
Vietti TJ; Valeriote FA; Kalish R; Coulter D
Cancer Treat Rep; 1978 Sep; 62(9):1313-20. PubMed ID: 688275
[TBL] [Abstract][Full Text] [Related]
16. [In vitro chemosensitivity test for testicular cancer using a human tumor stem cell assay].
Yamamoto N; Matsuyama H; Shinohara Y; Shimizu K; Sakatoku J
Nihon Gan Chiryo Gakkai Shi; 1985 Dec; 20(10):2229-35. PubMed ID: 2420907
[No Abstract] [Full Text] [Related]
17. Effect of oxygen on the cytotoxicity and antitumor activity of etoposide.
Teicher BA; Holden SA; Rose CM
J Natl Cancer Inst; 1985 Dec; 75(6):1129-33. PubMed ID: 3934448
[TBL] [Abstract][Full Text] [Related]
18. Effects of verapamil on etoposide, vincristine, and adriamycin activity in normal human bone marrow granulocyte-macrophage progenitors and in human K562 leukemia cells in vitro.
Yalowich JC; Zucali JR; Gross M; Ross WE
Cancer Res; 1985 Oct; 45(10):4921-4. PubMed ID: 3861238
[TBL] [Abstract][Full Text] [Related]
19. Relationship between in vitro tumor stem cell assay and in vivo antitumor activity using the P388 leukemia.
Marsh JC; Shoemaker RH; Salmon SE; Kern DH; Venditti JM
Int J Cell Cloning; 1988 Jan; 6(1):60-8. PubMed ID: 3339266
[TBL] [Abstract][Full Text] [Related]
20. Role of DNA breakage in cytotoxicity of doxorubicin, 9-deoxydoxorubicin, and 4-demethyl-6-deoxydoxorubicin in murine leukemia P388 cells.
Capranico G; De Isabella P; Penco S; Tinelli S; Zunino F
Cancer Res; 1989 Apr; 49(8):2022-7. PubMed ID: 2702645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
